全文获取类型
收费全文 | 23670篇 |
免费 | 1843篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 394篇 |
儿科学 | 820篇 |
妇产科学 | 392篇 |
基础医学 | 2428篇 |
口腔科学 | 525篇 |
临床医学 | 2157篇 |
内科学 | 5211篇 |
皮肤病学 | 547篇 |
神经病学 | 1285篇 |
特种医学 | 1103篇 |
外国民族医学 | 1篇 |
外科学 | 4549篇 |
综合类 | 326篇 |
一般理论 | 15篇 |
预防医学 | 1156篇 |
眼科学 | 822篇 |
药学 | 2040篇 |
中国医学 | 38篇 |
肿瘤学 | 1781篇 |
出版年
2023年 | 224篇 |
2022年 | 401篇 |
2021年 | 990篇 |
2020年 | 476篇 |
2019年 | 814篇 |
2018年 | 943篇 |
2017年 | 610篇 |
2016年 | 649篇 |
2015年 | 675篇 |
2014年 | 1017篇 |
2013年 | 1185篇 |
2012年 | 1750篇 |
2011年 | 1724篇 |
2010年 | 871篇 |
2009年 | 816篇 |
2008年 | 1285篇 |
2007年 | 1209篇 |
2006年 | 1124篇 |
2005年 | 983篇 |
2004年 | 883篇 |
2003年 | 749篇 |
2002年 | 653篇 |
2001年 | 587篇 |
2000年 | 550篇 |
1999年 | 488篇 |
1998年 | 160篇 |
1997年 | 135篇 |
1996年 | 138篇 |
1995年 | 142篇 |
1994年 | 113篇 |
1993年 | 97篇 |
1992年 | 268篇 |
1991年 | 284篇 |
1990年 | 248篇 |
1989年 | 212篇 |
1988年 | 208篇 |
1987年 | 219篇 |
1986年 | 192篇 |
1985年 | 177篇 |
1984年 | 111篇 |
1983年 | 126篇 |
1982年 | 85篇 |
1981年 | 70篇 |
1979年 | 129篇 |
1978年 | 77篇 |
1977年 | 69篇 |
1975年 | 58篇 |
1974年 | 65篇 |
1973年 | 88篇 |
1970年 | 58篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
John D. Koerner Neeraj M. Patel Richard S. Yoon Mark J. Gage Derek J. Donegan Frank A. Liporace 《Injury》2014
Objective
Intramedullary nailing (IMN) of obese patients with femoral fractures can be difficult due to soft tissue considerations and overall body habitus. Complications including malrotation can occur and have significant impact on postoperative function. The purpose of this study was to evaluate femoral rotation after intramedullary nailing of obese and non-obese patients to see if there was a difference in rotation, complications and any risk factors for malrotation.Materials and methods
Between 2000 and 2009, 417 consecutive patients with femur fractures treated with IM nail at Level I trauma and tertiary referral center. Of these, 335 with postoperative computed tomography (CT) scanogram of the bilateral lower extremities were included in this study. Baseline demographic, perioperative and postoperative femoral version calculations were included in the dataset. Statistical analysis included chi-squared test for categorical data, t-test for continuous data, and univariate and multivariate regression analysis. Significance was set at p < 0.05.Results
Of the 417 patients with femur fractures between 2000 and 2009, 335 met criteria for this study. There were 111 patients with a BMI <25, 129 with BMI 25–29.9, and 95 patients with a BMI >30. When BMI was categorised into 3 groups (<25, 25–29.9, or 30+), none of these groups were predictive of version in univariate or multivariate regressions. Among only obese patients (BMI 30+), BMI of 35+ was not a significant predictor of version when compared to BMI 30–34.9. There were no significant differences in femoral version based on entry point (antegrade vs. retrograde) in any BMI category. There were also no significant difference between groups of patients with a DFV of >15? (p = 0.212).Conclusions
Based on this study, BMI did not have an effect on postoperative difference in femoral version. In fact, in our multivariate regression analysis, BMI of over 30 was actually predictive of significantly lower difference in femoral version. While other studies have documented the intraoperative difficulties encountered with obese patients with femur fractures, the outcome of femoral rotation is not affected by an increasing BMI. 相似文献992.
993.
994.
995.
Izak Faiena Neal Patel Allen D Seftel 《Asian journal of andrology》2014,16(6):805-806
With increasing scrutiny of prostate cancer (PCa) diagnosis and treatment, much attention has been given to the morbidity caused by radical prostatectomy (RP) and/or radiotherapy (RT). One of the most common side-effects of either treatment is erectile dysfunction (ED).1 Approximately, 40% of patients will experience ED after RT for PCa. The post-RT ED causes significant patient dissatisfaction with cancer treatment as well as decrease in patient and partner psychosocial function,z To address this issue in patients undergoing RT, Pisansky et al.3 conducted a prospective, randomized, double-blinded, placebo-controlled trial to assess the efficacy of a phosphodiesterase enzyme-5 inhibitor (PDE5i), tadalafil, as a preventive measure for patients undergoing RT for PCa and found no difference in erectile function between the control and treatment groups. 相似文献
996.
Parotid metastatic disease from cutaneous squamous cell carcinoma: Prognostic role of facial nerve sacrifice,lateral temporal bone resection,immune status and P‐stage
下载免费PDF全文
![点击此处可从《Head & neck》网站下载免费的PDF全文](/ch/ext_images/free.gif)
997.
Abdallah El Sabbagh Vishal G. Patel Omar M. Jeroudi Tesfaldet T. Michael Mohammed E. Alomar Owen Mogabgab Eric Fuh Michele Roesle Bavana V. Rangan Shuaib Abdullah Jeffrey L. Hastings Jerrold Grodin Dharam J. Kumbhani Dimitrios Alexopoulos Panayotis Fasseas Subhash Banerjee Emmanouil S. Brilakis 《International journal of cardiology》2014
Background
The efficacy and safety profile of retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. We sought to perform a weighted meta-analysis of the success and complication rates of retrograde CTO PCI.Methods
We conducted a meta-analysis of 26 studies published between 2006 and April 2013 reporting in-hospital outcomes of retrograde CTO PCI. Data on procedural success, frequency of death, emergent coronary artery bypass graft surgery (CABG), stroke, myocardial infarction (MI), perforation, tamponade, stent thrombosis, major vascular or bleeding events, contrast nephropathy, and radiation skin injury were collected.Results
A total of 26 studies with 3482 patients and 3493 target CTO lesions were included. Primary retrograde CTO PCI was attempted in 52.4%. Pooled estimates of outcomes were as follows: procedural success 83.3% [95% confidence interval (CI): 79.0% to 87.7%]; death 0.7% (95% CI: 0.5% to 1.2%); urgent CABG 0.7% (95% CI: 0.4% to 1.2%); tamponade 1.4% (95% CI: 1.0% to 2.2%); collateral perforation 6.9% (95% CI: 4.6% to 10.4%); coronary perforation 4.3% (95% CI: 1.2% to 15.4%); donor vessel dissection 2% (95% CI: 0.9% to 4.5%); stroke 0.5% (95% CI: 0.2% to 1.0%); MI 3.1% (95% CI: 0.2% to 5.0%); Q wave MI 0.6% (95% CI: 0.4% to 1.1%); vascular access complications 2% (95% CI: 0.9% to 4.5%); contrast nephropathy 1.8% (95% CI: 0.8% to 3.7%); and wire fracture and equipment entrapment 1.2% (95% CI: 0.6% to 2.5%).Conclusions
Retrograde CTO PCI is associated with high procedural success rate and acceptable risk for procedural complications. 相似文献998.
999.
Background
Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death worldwide. There are widespread global differences in HCC risk. Although the impact of geographic prevalence of specific causes of chronic liver disease on HCC is recognized, the contribution of the underlying genetic architecture to the risk of HCC remains undefined. Our aim was to characterize evolutionary trends in genetic susceptibility to HCC.Methods
We examined the genetic risk associated with HCC risk alleles identified from genome-wide association studies and correlated these with geographic location and temporal and spatial patterns of human migration.Results
A moderate increase in differentiation was noted for rs2596542 (F st = 0.106) and rs17401966 (F st = 0.116), single nucleotide polymorphisms (SNPs) associated with an increased risk of HCC in patients with chronic HCV and HBV, respectively. Both of these SNPs show a recent increase in allelic frequency with the most recent human migrations into East Asia, Oceania and the Americas. In contrast another SNP associated with an increased risk of HCC, rs9275572, showed a lack of differentiation (F st = 0.09) with stable allelic expression across populations. The genetic risk score for HCC, based on the allelic frequency and risk odds ratio of five SNPs associated with increased risk of HCC, was greatest in populations from Africa and decreased with subsequent migration into Europe and Asia. However, a major increase was noted with the most recent migrations into Oceania and the Americas.Conclusions
There are differences in directional differentiation of HCC risk alleles across human populations that can contribute to population-based differences in HCC prevalence. 相似文献1000.